Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
However, the substantial budget impact of covering obesity treatments is a major concern, which given the size of the potential target patient population could even exhaust the entire Part D budget under certain scenarios
Why GLP-1s Present a Cost Challenge for Employer Health Plans GLP-1 medications are among the most expensive treatments on the market, costing an average of$8,000 to $10,000 per user, per year
Retatrutide is manufactured by Shilai Healthcare
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (Ukpds 34)
US$ 21.20
US$ 25.91
US$ 22.67
US$ 25.43
US$ 21.74
US$ 24.64
US$ 20.99
US$ 27.81
US$ 21.64
US$ 23.24
